Tech Company Financing Transactions
Omeza Funding Round
On 4/22/2026, Omeza raised $8.5 million in Series A funding from Astanor Ventures, Catalyst Investments and Florida Opportunity Fund.
Transaction Overview
Company Name
Announced On
4/22/2026
Transaction Type
Venture Equity
Amount
$8,500,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1610 Northgate Blvd
Sarasota, FL 34234
USA
Sarasota, FL 34234
USA
Phone
Website
Email Address
Overview
Omeza® is a skin health company based in Sarasota, FL USA. Our mission is to restore skin integrity for people with serious skin problems and to optimize skin quality for all. Omeza end-users are people who have or are at risk for developing chronic wounds due to aging -- exacerbated by comorbidities including diabetes, obesity, chronic venous insufficiency, peripheral artery disease and autoimmune disease. Current standard care is ineffective, with wound closure hindered by biofilm, excessive debridement, and inadequate provider training that results in stalled wounds and expensive, often ineffective advanced wound care treatments. These wounds frequently result in costly hospital admissions and amputations.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Cynthia Flowers
Chief Scientific Officer
Suzanne Bakewell
Browse more venture capital transactions:
Prev: 4/22/2026: Courier Health venture capital transaction
Next: 4/22/2026: Nephronomics venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs